Figure 1 4.1.1 Cardiovascular outcomes in SGLT2 inhibitors: safety studies The EMPA-REG OUTCOME trial, which included 7020 patients with T2DM, was the first to demonstrate the cardiovascular protective effects of empagliflozin ( Subsequent trials, such as CANVAS and DECLARE-TIMI 58, have further confirmed the cardiovascular benefits of SGLT-2 inhibitors
Among the drug classes under investigation for AD are the glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are approved for the treatment of type 2 diabetes (T2D), obesity and cardiovascular disease
The Royal Institution of Chartered Surveyors is our governing body
However, side effects can occur, and long-term safety data are limited
Plant Extracts Ingredients like licorice root extract, mulberry extract, and bearberry extract are often included for their natural skin-brightening and anti-inflammatory properties
Instead of calming pain long term, opioids can remodel pain-processing circuits in the brain and spinal cord, making normal sensations feel more painful